Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -73,312 | -55,031 | -53,160 | -37,279 | N/A |
| Depreciation Amortization | 4,763 | 2,620 | 1,731 | 1,259 | N/A |
| Accounts receivable | -648 | 20,116 | -24,004 | -697 | N/A |
| Other Working Capital | 58,486 | 20,103 | 45,241 | 2,140 | N/A |
| Other Operating Activity | 7,266 | -13,319 | 23,433 | 1,045 | 0 |
| Operating Cash Flow | $-3,445 | $-25,511 | $-6,759 | $-33,532 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,503 | -21,460 | -2,650 | -2,821 | N/A |
| Purchase Of Investment | -26,673 | -82,613 | -87,839 | -36,994 | N/A |
| Sale Of Investment | 48,455 | 90,465 | 62,880 | 34,200 | N/A |
| Other Investing Activity | -521 | -1,465 | 0 | 0 | 0 |
| Investing Cash Flow | $17,758 | $-15,073 | $-27,609 | $-5,615 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,079 | N/A | 1,640 | 1,953 | N/A |
| Debt Repayment | -1,250 | -1,004 | -920 | -3,892 | N/A |
| Common Stock Issued | 272 | 179 | 47 | 100 | N/A |
| Other Financing Activity | 41,562 | 49,388 | 49,951 | 81,929 | 0 |
| Financing Cash Flow | $41,663 | $48,563 | $50,718 | $80,090 | $N/A |
| Beginning Cash Position | 66,330 | 58,351 | 46,077 | 5,134 | N/A |
| End Cash Position | 122,306 | 66,330 | 62,427 | 46,077 | N/A |
| Net Cash Flow | $55,976 | $7,979 | $16,350 | $40,943 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,445 | -25,511 | -6,759 | -33,532 | N/A |
| Capital Expenditure | -3,524 | -21,465 | -2,651 | -2,822 | N/A |
| Free Cash Flow | -6,969 | -46,976 | -9,410 | -36,354 | 0 |